Poster 58

Real-world evidence demonstrating risk stratification of the 31-GEP and i31-GEP in patients with stage I-III cutaneous melanoma

Authors: David Pariser, MD1 Jeffrey Sussman, MD, Brian Martin, PhD, Lindsay Ackerman, MD, Craig Kraffert, MD, Abel Jarell, MD

<PREVIOUS POSTER | NEXT POSTER>

Poster 58